Lantheus Holdings Stock News

Lantheus, Progenics agree to amended transaction terms LNTH PGNX

Lantheus Holdings, Inc. (NASDAQ: LNTH) ("Lantheus"), parent company of Lantheus Medical Imaging, Inc. ("LMI"), a leader in the development, manufacture and commercialization of innovative diagnostic i

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 18) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Anavex

Valuation metrics in the healthcare sector. Evolution since last month. A list of stocks looking cheap in their industries.

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the developmen

Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH) today announced that it will host a conference call at 8:00 a.m. ET on Tuesday, February 25, 2020, to discuss its financial and operating results

Progenics is still set to be acquired by Lantheus Holdings in an all-stock transaction. Both stocks have dropped around 20%-25% over the past three months makin

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

BidaskClub cut shares of Lantheus (NASDAQ:LNTH) from a sell rating to a strong sell rating in a research note issued to investors on Friday, BidAskClub reports. Separately, ValuEngine raised shares of

The "Biological Imaging Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.

Lantheus Holdings, Inc. (NASDAQ:LNTH) shareholders might be concerned after seeing the share price drop 17% in the...

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (“Lantheus” or the “Company”), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a leader in the dev

If this week is any indication, the steady march of life science companies to Wall Street will continue in 2020. Black Diamond Therapeutics is leading the

Lantheus Holdings has appointed Paul Blanchfield to serve as its chief commercial officer. Blanchfield was most recently head of US immunology at Takeda

Anyone researching Lantheus Holdings, Inc. (NASDAQ:LNTH) might want to consider the historical volatility of the share...